F-Prime Capital is a global venture capital firm that primarily invests in healthcare and technology sectors. Within healthcare, they focus on therapeutics, medtech, and healthtech + services, while their technology investments span enterprise software, fintech, frontier tech, and crypto. The firm is generally an early-stage investor but is stage-agnostic, supporting exceptional teams at any stage of growth.
35% of their portfolio is in Healthcare. Average disclosed round size is $63.0M (across 117 rounds with reported amounts).
Portfolio
121
Fund Size
$4.5B
Top Stage
Series B
Last 12 Mo
17
Team
RW
Rocio Wu
Principal
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
121 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Jump | Series B | $80M | Feb 2026 |
 Monark Markets | Strategic | $8.1M | Feb 2026 |
 Tenpoint Therapeutics | Series B | $85M | Jan 2026 |
 Meld | Series A | $7M | Jan 2026 |
 Paradigm Health | Series B | $78M | Dec 2025 |
 WellBeam | Series A | $10M | Nov 2025 |
| TT-Therapeutics | Series A | $91M | Nov 2025 |
| AABK Biomedical, Inc. | Series D | $35M | Oct 2025 |
 Kanastra | Series B | $30M | Oct 2025 |
 AmplifyMD | Series B | $20M | Sep 2025 |
 Charm Therapeutics | Series B | $68.5M | Sep 2025 |
 ARTBIO | Series B | $132M | Jul 2025 |
 Spinwheel | Series A | $30M | Jun 2025 |
 Canary | Series D | $80M | Jun 2025 |
 Canary Technologies | Series D | $80M | Jun 2025 |
 Axle Health | Series A | $10M | May 2025 |
 Toku | Series A | $48M | Apr 2025 |
 Atalanta Therapeutics | Series B | $75M | Jan 2025 |
 Tenvie Therapeutics | Series D | $200M | Jan 2025 |
 Ethena | Growth | $100M | Dec 2024 |
 TripSuite | Seed | $5M | Dec 2024 |
 Lighthouse | Series C | $370M | Nov 2024 |
 Teleo | Series A | $16.2M | Nov 2024 |
 Notabene | Series B | $14.5M | Nov 2024 |
 Chaos Labs | Series A | $55M | Aug 2024 |
Page 1 of 5
Top Co-Investors
Eight Roads Ventures19 shared
GV (Google Ventures)11 shared
Y Combinator10 shared
ARCH Venture Partners8 shared
Oak HC/FT8 shared
General Catalyst7 shared
Insight Partners6 shared
.406 Ventures6 shared
Thayer Ventures6 shared
Bain Capital Ventures5 shared
Polaris Venture Partners5 shared
OrbiMed5 shared
Maverick Ventures5 shared
Temasek Holdings4 shared
Andreessen Horowitz4 shared
Khosla Ventures4 shared
NEA (New Enterprise Associates)4 shared
Jazz Venture Partners4 shared
Gradient Ventures3 shared
Omega Funds3 shared
Last updated: 8 March 2026